Cochlear Stock

Cochlear Net Margin

The Net Profit Margin of Cochlear (COH.AX) as of Sep 3, 2026 is 16.60 %. In the previous year, Net Profit Margin was 15.96 % — a change of 4.00% (higher).

Net Margin

16.60 %

YoY

4.00%

Last updated:

Net Profit Margin of Cochlear is 2026 16.60 % . Net Profit Margin of Cochlear was 2025 15.96 % . It decreases by 4.00% higher compared to the previous year.

For Cochlear, the net margin of 16.6% is down versus 21.8% a few years ago.

The Cochlear Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
18.02 AUD
Jan 1, 2019
19.39 AUD
Jan 1, 2020
-18.04 AUD
Jan 1, 2021
21.80 AUD
Jan 1, 2022
17.54 AUD
Jan 1, 2023
15.53 AUD
Jan 1, 2024
15.96 AUD
Jan 1, 2025
16.60 AUD
The Cochlear Net Margin history
YEARNet MarginYoY
16.60 %+4.00%
15.96 %+2.79%
15.53 %-11.48%
17.54 %-19.55%
21.80 %-220.82%
-18.04 %-193.04%
19.39 %+7.60%
18.02 %+1.07%
17.83 %+6.73%
16.71 %+6.06%
15.76 %+35.34%
11.64 %+6,508.09%
0.18 %+141.61%
0.07 %-67.22%
0.22 %+5.32%
0.21 %+12.44%
0.19 %-1.88%
0.19 %+6.99%
0.18 %+1.17%
0.18 %
Access this data via the Eulerpool API

Cochlear Stock analysis

What does Cochlear do? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cochlear stock

Net Profit Margin of Cochlear is 16.60 % in 2026.

Net Profit Margin of Cochlear changed from 15.96 % to 16.60 %, representing a 4.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Cochlear since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Cochlear with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

Margins — Cochlear

All Key Metrics — Cochlear